Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver Nitrate Cauterization for Tympanic Membrane Perforation
NCT07833670Terminated
- Start
- Feb 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label trial of silver nitrate in tympanic membrane perforation (2 arms). Primary endpoint: Tympanic Membrane Perforation Closure Rate at 4 weeks. Started Feb 2026; status: terminated.
02
Drugs
silver nitrate
03
Conditions
tympanic membrane perforation
Beyond the preview
Go deeper on NCT07833670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07833670.